Product Name :
Ceranib1
Description:
Ceranib1 is a ceramidase inhibitor. Ceranib1 inhibits ceramidase activity toward an exogenous ceramide analog, induces the accumulation of multiple ceramide species, decreases levels of sphingosine and S1P. Ceranib1 inhibits the proliferation of ovarian cancer cells.
CAS:
328076-61-5
Molecular Weight:
395.45
Formula:
C26H21NO3
Chemical Name:
3-[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]-6-methyl-4-phenyl-1,2-dihydroquinolin-2-one
Smiles :
CC1C=C2C(=CC=1)NC(=O)C(=C2C1C=CC=CC=1)C(=O)/C=C/C1C=CC(=CC=1)OC
InChiKey:
OJMCCNQNCSCAJV-RVDMUPIBSA-N
InChi :
InChI=1S/C26H21NO3/c1-17-8-14-22-21(16-17)24(19-6-4-3-5-7-19)25(26(29)27-22)23(28)15-11-18-9-12-20(30-2)13-10-18/h3-16H,1-2H3,(H,27,29)/b15-11+
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Ceranib1 is a ceramidase inhibitor.{{Plasmin} web|{Plasmin} Apoptosis|{Plasmin} Biological Activity|{Plasmin} In Vivo|{Plasmin} custom synthesis|{Plasmin} Epigenetics} Ceranib1 inhibits ceramidase activity toward an exogenous ceramide analog, induces the accumulation of multiple ceramide species, decreases levels of sphingosine and S1P.{{Sarolaner} MedChemExpress|{Sarolaner} Anti-infection|{Sarolaner} Biological Activity|{Sarolaner} Purity|{Sarolaner} custom synthesis|{Sarolaner} Epigenetic Reader Domain} Ceranib1 inhibits the proliferation of ovarian cancer cells.PMID:23891445 |Product information|CAS Number: 328076-61-5|Molecular Weight: 395.45|Formula: C26H21NO3|Chemical Name: 3-[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]-6-methyl-4-phenyl-1,2-dihydroquinolin-2-one|Smiles: CC1C=C2C(=CC=1)NC(=O)C(=C2C1C=CC=CC=1)C(=O)/C=C/C1C=CC(=CC=1)OC|InChiKey: OJMCCNQNCSCAJV-RVDMUPIBSA-N|InChi: InChI=1S/C26H21NO3/c1-17-8-14-22-21(16-17)24(19-6-4-3-5-7-19)25(26(29)27-22)23(28)15-11-18-9-12-20(30-2)13-10-18/h3-16H,1-2H3,(H,27,29)/b15-11+|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|Ceranib1 produces a dose-dependent decrease in ceramidase activity, with 50% inhibition at 55 and 28 μM in SKOV3 cells. Ceranib1 (24 hours) does not cause significant acute cytotoxicity at concentrations up to at least those used in the ceramidase assay in SKOV3 cells. Ceranib1 prevents the hydrolysis of endogenous ceramide species and reduces intracellular sphingosine and S1P. Ceranib1 (10 nM-10 μM; 72 hours) exhibits antiproliferative activity for SKOV3 cells.|Products are for research use only. Not for human use.|
